Effects of climatic region on peritonitis risk, microbiology, treatment, and outcomes: A multicenter registry study

Peritoneal Dialysis International

Volumn 33, Issue 1, 2013, Pages 75-85

  Cho, Yeoungjee ^a,b   Badve, Sunil V ^a,b   Hawley, Carmel M ^a,b   McDonald, Stephen P ^a,c   Brown, Fiona G ^a,d   Boudville, Neil ^a,e   Wiggins, Kathryn J ^a,f   Bannister, Kym M ^a,c   Clayton, Philip ^a,g   Johnson, David W ^a,b  

^a Australia and New Zealand Dialysis and Transplant Registry   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

^d MONASH MEDICAL CENTRE   (Australia)

^e UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^f ROYAL MELBOURNE HOSPITAL   (Australia)

^g ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Antibiotics; Bacteria; Climate; Fungus; Microbiology; Outcomes; Peritonitis

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; CEFAZOLIN; CEPHALOSPORIN DERIVATIVE; GENTAMICIN; NYSTATIN; VANCOMYCIN;

ADULT; ARTICLE; CONTROLLED STUDY; DESERT; DISEASE FREE SURVIVAL; FEMALE; GEOGRAPHIC AND GEOLOGICAL PHENOMENA; GEOGRAPHIC DISTRIBUTION; HOSPITALIZATION; HUMAN; INFECTION RATE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERITONEAL DIALYSIS; PERITONITIS; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SEASONAL VARIATION; SUBTROPICAL REGION; SURVIVAL RATE; SURVIVAL TIME; TEMPERATE GRASSLAND; TEMPERATE REGION; TROPICS;

ANTI-INFLAMMATORY AGENTS; CLIMATE CHANGE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PERITONITIS; PROGNOSIS; QUEENSLAND; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS;

EID: 84878983938     PISSN: 08968608     EISSN: 17184304     Source Type: Journal    
DOI: 10.3747/pdi.2011.00317     Document Type: Article

References (28)

1. Johnson DW, Chang S, Excell L, Livingston B, Bannister K, McDonald SP. Peritoneal dialysis. In: McDonald S, Chang S, Excell L, eds. The Twenty-Ninth Report Australia and New Zealand Dialysis and Transplant Registry 2006. Adelaide, Australia: ANZDATA Registry; 2007: 87-103.
2. Barraclough K, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, et al. Polymicrobial peritonitis in peritoneal dialysis patients in Australia: predictors, treatment, and outcomes. Am J Kidney Dis 2010; 55:121-31.
3. Barraclough K, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, et al. Corynebacterium peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 82 cases. Nephrol Dial Transplant 2009; 24:3834-9.
4. Edey M, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, et al. Enterococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 116 cases. Nephrol Dial Transplant 2009; 25:1272-8.
5. Fahim M, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, et al. Culture-negative peritonitis in peritoneal dialysis patients in Australia: predictors, treatment, and outcomes in 435 cases. Am JKidney Dis 2009; 55:690-7.
6. Fahim M, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, et al. Coagulase-negative staphylococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 936 cases. Nephrol Dial Transplant 2010; 25:3386-92.
7. Govindarajulu S, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, et al. Staphylococcus aureus peritonitis in Australian peritoneal dialysis patients: predictors, treatment, and outcomes in 503 cases. Perit Dial Int 2009; 30:311-19.
8. Jarvis EM, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, et al. Predictors, treatment, and outcomes of non-Pseudomonas gram-negative peritonitis. Kidney Int 2010; 78:408-14.
9. Jose MD, Johnson DW, Mudge DW, Tranæus A, Voss D, Walker R, et al. Peritoneal dialysis practice in Australia and New Zealand: a call to action. Nephrology (Carlton) 2011; 16:19-29.
10. Miles R, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, et al. Predictors and outcomes of fungal peritonitis in peritoneal dialysis patients. Kidney Int 2009; 76:622-8.
11. O'Shea S, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, et al. Streptococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 287 cases. BMC Nephrol 2009; 10:19.
12. Siva B, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, et al. Pseudomonas peritonitis in Australia: predictors, treatment, and outcomes in 191 cases. Clin JAm Soc Nephrol 2009; 4:957-64.
13. Kim MJ, Song JH, Park YJ, Kim GA, Lee SW. The influence of seasonal factors on the incidence of peritonitis in continuous ambulatory peritoneal dialysis in the temperate zone. Adv Perit Dial 2000; 16:243-7.
14. Szeto CC, Chow KM, Wong TY, Leung CB, Li PK. Influence of climate on the incidence of peritoneal dialysis-related peritonitis. Perit Dial Int 2003; 23:580-6.
15. Quinn MJ, Hasbargen JA, Hasbargen BJ. When does peritonitis occur? Perit Dial Int 1994; 14:172-4.
16. Alves FR, Dantas RC, Lugon JR. Higher incidence of catheter-related infections in a tropical climate. Adv Perit Dial 1993; 9:244-7.
17. Chan MK, Chan CY, Cheng IK, Ng WS. Climatic factors and peritonitis in CAPD patients. Int J Artif Organs 1989; 12:366-8.
18. Piraino B, Bailie GR, Bernardini J, Boeschoten E, Gupta A, Holmes C, et al. Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int 2005; 25:107-31.
19. Piraino B, Bernardini J, Brown E, Figueiredo A, Johnson DW, Lye WC, et al. ISPD position statement on reducing the risks of peritoneal dialysis-related infections. Perit Dial Int 2011; 31:614-30.
20. Johnson D, Brown F, Lammi H, Walker R on behalf of Caring for Australians with Renal Impairment (CARI). The CARI guidelines. Dialysis adequacy (PD) guidelines. Nephrology (Carlton) 2005; 10(Suppl 4):S81-107.
21. The CARI guidelines. Evidence for peritonitis treatment and prophylaxis: type of peritoneal dialysis catheter. Nephrology 2004; 9(Suppl 3):S59-64.
22. The CARI guidelines. Evidence for peritonitis treatment and prophylaxis: treatment of peritoneal dialysis-associated peritonitis in adults. Nephrology (Carlton) 2004; 9(Suppl 3):S91-106.
23. Martin LC, Caramori JC, Fernandes N, Divino-Filho JC, Pecoits-Filho R, Barretti P on behalf of the Brazilian Peritoneal Dialysis Multicenter Study BRAZPD Group. Geographic and educational factors and risk of the first peritonitis episode in Brazilian Peritoneal Dialysis Study (BRAZPD) patients. Clin JAm Soc Nephrol 2011; 6:1944-51.
24. Stinghen AE, Barretti P, Pecoits-Filho R. Factors contributing to the differences in peritonitis rates between centers and regions. Perit Dial Int 2007; 27(Suppl 2):S281-5.
25. Matuszkiewicz-Rowinska J. Update on fungal peritonitis and its treatment. Perit Dial Int 2009; 29(Suppl 2):S161-5.
26. Gow NA, Brown AJ, Odds FC. Fungal morphogenesis and host invasion. Curr Opin Microbiol 2002; 5:366-71.
27. Lo WK, Chan CY, Cheng SW, Poon JF, Chan DT, Cheng IK. A prospective randomized control study of oral nystatin prophylaxis for Candida peritonitis complicating continuous ambulatory peritoneal dialysis. Am JKidney Dis 1996; 28:549-52.
28. Restrepo C, Chacon J, Manjarres G. Fungal peritonitis in peritoneal dialysis patients: successful prophylaxis with fluconazole, as demonstrated by prospective randomized control trial. Perit Dial Int 2010; 30:619-25.